(Q37174039)

18 August 2017

1 reference

title

Frontiers in the surgical treatment of Parkinson's disease (English)

1 reference

18 August 2017

1 reference

1

Remple MS

1 reference

18 August 2017

2

Sarpong Y

1 reference

18 August 2017

3

Neimat JS

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

897-906

1 reference

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

A randomized trial of deep-brain stimulation for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

The pedunculopontine nucleus and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

The pedunculopontine nucleus in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Deep brain stimulation of the pedunculopontine region in the normal non-human primate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Two-year follow-up of chronic stimulation of the posterior subthalamic white matter for tremor-dominant Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Extradural motor cortex stimulation for advanced Parkinson disease. Report of two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Targets for deep brain stimulation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Prevention of neurotoxin damage of 6-OHDA to dopaminergic nigral neuron by subthalamic nucleus lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Protection of nigral cell death by bilateral subthalamic nucleus stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Does increased excitatory drive from the subthalamic nucleus contribute to dopaminergic neuronal death in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Regional and cell-specific expression of GDNF in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Functional recovery in parkinsonian monkeys treated with GDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Toward trophic treatment in parkinsonism: a primate step

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Neurturin, a relative of glial-cell-line-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Neurturin, persephin, and artemin in the human pre- and full-term newborn and adult hippocampus and fascia dentata

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Enovin, a member of the glial cell-line-derived neurotrophic factor (GDNF) family with growth promoting activity on neuronal cells. Existence and tissue-specific expression of different splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Derivation of midbrain dopamine neurons from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor age

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Grafts of adult subependymal zone neuronal progenitor cells rescue hemiparkinsonian behavioral decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Long term role of pergolide as an adjunct therapy in Parkinson's disease: influence on disability, blood pressure, weight and levodopa syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Functional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Potential of gene therapy for pediatric neurotransmitter diseases: lessons from Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Subthalamic GAD gene therapy in a Parkinson's disease rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

Isolation of multipotent adult stem cells from the dermis of mammalian skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.6.897

21 January 2018

Identifiers

DOI

10.1586/14737175.8.6.897

1 reference

18 August 2017

1 reference